Brief: Akebia Therapeutics Provides Update On Form 10-Q Filing

Akebia Therapeutics

10/08/2023 23:12

Aug 10 (Reuters) - Akebia Therapeutics Inc  AKBA.O :
    * AKEBIA THERAPEUTICS PROVIDES UPDATE ON FORM 10-Q FILING
    * AKEBIA THERAPEUTICS - ANNOUNCES LATE FILING OF ITS Q2
EARNINGS
AND FORM 10-Q
    * AKEBIA THERAPEUTICS INC - REAFFIRMS 2023 NET PRODUCT
REVENUE
GUIDANCE OF $175 - $180 MILLION
    * AKEBIA THERAPEUTICS - BELIEVES CASH RESOURCES AS OF JUNE
30,
2023 TO BE SUFFICIENT TO FUND ITS CURRENT OPERATING PLAN THROUGH
AT LEAST NEXT 12 MONTHS
    * AKEBIA THERAPEUTICS INC - EXPECTS TO RESUBMIT NDA FOR
VADADUSTAT
AS A TREATMENT FOR ANEMIA DUE TO CKD IN ADULT PATIENTS ON
DIALYSIS IN Q3 2023

Source text for Eikon:  ID:nPn2RTjh0a 
Further company coverage:  AKBA.O 

 ((Reuters.Briefs@thomsonreuters.com;))